May 2, 2026
Masonic Iran Participated in the WHO COVID HOAX
Iran's participation in the COVID Hoax tells me the current war is a charade. Iran is being portrayed in the
Communist Jewish Western media as offended party rather than the main obstacle to Israeli domination of the Middle East.
Did Iran vaccinate its citizens during the COVID pandemic? Dis it fully participate in the worldwide response?
by GROK 4
(henrymakow.com)
Yes, Iran vaccinated its citizens during the COVID-19 pandemic, though coverage was initially slow and reached moderate levels compared to many other countries.
Vaccination Campaign Details---Iran launched its vaccination drive in February 2021, prioritizing healthcare workers, the elderly (over 65), and high-risk groups. It relied heavily on imported vaccines (especially China's Sinopharm, which made up the bulk) alongside Russian Sputnik V and others, plus limited COVAX supplies. Domestic production (e.g., COVIran Barekat, which Supreme Leader Ali Khamenei received) supplemented this but played a smaller role overall.
By late 2021, Iran had fully vaccinated around 50% of its population. Coverage improved over time. By December 2022 (roughly 2.5 years in), Iran administered over 155 million doses to about 65.9 million people (roughly 74-77% of the ~85 million population received at least one dose; second-dose coverage was around 69-70%). Doses per 100 people reached ~175 by late 2023.
Some vaccine hesitancy existed (driven by concerns over side effects, distrust, conspiracy theories, and access issues), but overall uptake was significant, especially among adults.
health-providers.ir
Iran produced several domestic vaccines and eventually reduced imports as local supply grew, though none of its homegrown options received WHO approval.
iranintl.com
Yes, Iran participated in the WHO-led global response, including as a self-financing member of the COVAX facility.
Participation in WHO/COVAXIran was a self-financing participant in COVAX (not an AMC/low-income recipient) and received multiple shipments of vaccines (e.g., AstraZeneca batches starting in April 2021, Sinopharm, and donations channeled through the facility from countries like Japan, Italy, and Germany).
It received over 10 million doses via COVAX overall, plus additional humanitarian buffer doses for refugees. WHO collaborated with Iran's Ministry of Health on deliveries, training, risk communication, genomic sequencing, and adverse event monitoring.
Broader cooperation included WHO support for Iran's response, though the country also pursued bilateral deals (heavily with China) due to sanctions and other factors.
In summary, Iran ran a national vaccination program with substantial (though not universal) coverage and engaged with the WHO/COVAX system while supplementing it through its own production and other imports. Its approach reflected a mix of international collaboration and domestic/self-reliance priorities amid geopolitical constraints. Data comes primarily from WHO reports, official Iranian health statistics, and independent trackers.
